Biotech investors in Boston, Massachusetts
Updated 16 Nov 2026
Venture funds
1 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | MassVentures MassVentures supports Massachusetts-based startups, with recent backings including Emvolon and EnVision Endoscopy. Boston, United States |
Health care, Hardware | Seed, Early stage venture, Late stage venture | 26% | 2 |
Table 1. Biotech investors in Boston, Massachusetts: venture capital and micro VC funds ranked by biotech companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| RA Capital Management | Startup incubator | Boston, United States | •••@racap.com | 617.77••• |
| MassChallenge | Startup accelerator | Boston, United States | •••@masschallenge.org | |
| Polaris Partners | Private equity firm | Boston, United States | •••@polarispartners.com | +1 855••• |
| Omega Funds | Secondary purchaser | Boston, United States | •••@omegafunds.net | |
| MPM Capital | Private equity firm | Boston, United States | •••@mpmcapital.com | +1 617••• |
| Wellington Management | Private equity firm | Boston, United States | •••@wellington.com | 617-95••• |
| SV Health Investors | Private equity firm | Boston, United States | •••@svlsa.com | +1 617••• |
| Bain Capital Life Sciences | Private equity firm | Boston, United States | •••@baincapital.com |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
| Firm | Person | Title | Verified email | |
|---|---|---|---|---|
| RA Capital Management | P••• K••• | Managing Partner | p•••@racap.com | In the CSV |
| Polaris Partners | J••• F••• | Founding Partner | j•••@polarispartners.com | In the CSV |
| MPM Capital | C••• B••• M••• | Co Managing Partner | c•••@mpmcapital.com | In the CSV |
| Wellington Management | J••• H••• | CEO, Managing Partner, and Portfolio Manager | j•••@wellington.com | In the CSV |
| SV Health Investors | K••• B••• | Managing Partner | k•••@svhealthinvestors.com | In the CSV |
5 verified partner contact rows from organizations on this list, names and emails masked.
- 22 of the 33 biotech investors in Boston, Massachusetts have a published email address, 17 a phone number and 33 a website.
- RA Capital Management has the most recorded investments, 544, 183 of them as lead investor.
- 24 of them are investors in at least one company that closed its most recent round in the last 12 months.
- MassChallenge is an investor in 26 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is Light Frame's $5.1M seed round on 10 November 2026.
- Software is the most common sector across their 783 portfolio companies (67%).
- Early stage venture is the most common investment stage, recorded for 31 of them (94%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Biotech investors in Boston, Massachusetts
30 of 33, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RA Capital Management | Startup incubator, Private equity firm | Boston, United States | Health care, Biotech | Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics | 9 | 544 | 183 | 243 | •••@racap.com | 617.77••• | In the CSV |
| 2 | MassChallenge | Startup accelerator | Boston, United States | Artificial intelligence, Health care | HELIOS, DrizzleX, ScribeUp | 26 | 3,225 | 1,037 | 267 | •••@masschallenge.org | In the CSV | |
| 3 | Polaris Partners | Private equity firm, Venture capital firm | Boston, United States | Health care, Artificial intelligence | Faro AI, Triveni Bio, Whisker Labs | 3 | 754 | 215 | 207 | •••@polarispartners.com | +1 855••• | In the CSV |
| 4 | Fidelity | Investment bank | Boston, United States | Health care, Hardware | Zipline International, Tenstorrent, SiMa.ai | 7 | 586 | 178 | 285 | +1-866••• | In the CSV | |
| 5 | Cormorant Asset Management | Hedge fund | Boston, United States | Health care, Biotech | Triveni Bio, Third Arc Bio, BlossomHill Therapeutics | 4 | 276 | 58 | 141 | In the CSV | ||
| 6 | Omega Funds | Secondary purchaser, Venture capital firm | Boston, United States | Biotech, Health care | FoRx Therapeutics | 1 | 161 | 37 | 75 | •••@omegafunds.net | In the CSV | |
| 7 | MPM Capital | Private equity firm, Venture capital firm | Boston, United States | Biotech, Health care | Reunion Neuroscience, Umoja Biopharma, āshibio | 301 | 97 | 105 | •••@mpmcapital.com | +1 617••• | In the CSV | |
| 8 | Wellington Management | Private equity firm, Venture capital firm | Boston, United States | Fintech, Health care | Tabby, Current, Element Biosciences | 4 | 335 | 111 | 160 | •••@wellington.com | 617-95••• | In the CSV |
| 9 | SV Health Investors | Private equity firm, Venture capital firm | Boston, United States | Health care, Biotech | Alchemab Therapeutics | 1 | 325 | 76 | 95 | •••@svlsa.com | +1 617••• | In the CSV |
| 10 | Bain Capital Life Sciences | Private equity firm, Venture capital firm | Boston, United States | Biotech, Health care | CereVasc | 1 | 117 | 41 | 60 | •••@baincapital.com | ||
| 11 | Third Rock Ventures | Venture capital firm | Boston, United States | Biotech, Health care | Terremoto Biosciences | 1 | 154 | 69 | 44 | •••@thirdrockventures.com | (415) ••• | In the CSV |
| 12 | Half Court Ventures | Venture capital firm | Boston, United States | Artificial intelligence, Hardware | Light Frame, Flow Labs, Beacon Biosignals | 4 | 89 | 1 | 17 | In the CSV | ||
| 13 | Taihill Venture | Venture capital firm | Boston, United States | Biotech, Artificial intelligence | Kano Therapeutics, Bot Auto, LeyLine | 65 | 2 | 4 | •••@taihill.vc | In the CSV | ||
| 14 | MassVentures | Venture capital firm | Boston, United States | Health care, Hardware | Emvolon, ZwitterCo, Kytopen | 6 | 476 | 122 | 83 | •••@mass-ventures.com | +1 617••• | In the CSV |
| 15 | Pillar VC | Venture capital firm | Boston, United States | Artificial intelligence, Health care | Addis Energy, OpenHands | 2 | 149 | 26 | 18 | •••@pillar.vc | 857-40••• | In the CSV |
| 16 | PharmStars | Startup accelerator | Boston, United States | Health care, Artificial intelligence | Triomics, Medra AI | 2 | 68 | 62 | 4 | In the CSV | ||
| 17 | Vida Ventures | Venture capital firm | Boston, United States | Biotech, Health care | InduPro | 1 | 67 | 23 | 25 | •••@vidaventures.com | 857-25••• | In the CSV |
| 18 | Innospark Ventures | Venture capital firm | Boston, United States | Artificial intelligence, Biotech | VODA.ai, Persist AI, VideaHealth | 56 | 18 | 5 | In the CSV | |||
| 19 | Broadview Ventures | Venture capital firm | Boston, United States | Health care, Biotech | CroíValve | 1 | 75 | 19 | 12 | •••@broadviewventures.org | 617-34••• | In the CSV |
| 20 | Longwood Fund | Venture capital firm | Boston, United States | Health care, Biotech | Channel Medsystems | 1 | 74 | 11 | 19 | •••@longwoodfund.com | (617)3••• | In the CSV |
| 21 | MP Healthcare Venture Management | Corporate venture arm | Boston, United States | Biotech, Health care | Draupnir Bio, Outrun TX, Covagen | 46 | 4 | 10 | •••@mp-healthcare.com | 617-73••• | ||
| 22 | Iaso Ventures | Venture capital firm | Boston, United States | Biotech, Artificial intelligence | Prudentia Sciences | 1 | 15 | 0 | 1 | •••@iasoventures.com | In the CSV | |
| 23 | HarbourVest Partners | Private equity firm | Boston, United States | Fintech, Hardware | Varo Bank | 1 | 273 | 52 | 147 | •••@harbourvest.com | +1 617••• | In the CSV |
| 24 | Castor Ventures | Venture capital firm | Boston, United States | Artificial intelligence, Health care | Pie Systems, Sorcero | 2 | 167 | 3 | 39 | In the CSV | ||
| 25 | RockPort Capital | Venture capital firm | Boston, United States | Hardware, Biotech | NewLeaf Symbiotics, EcoFactor, Gazelle | 108 | 25 | 26 | 415-78••• | In the CSV | ||
| 26 | Glasswing Ventures | Venture capital firm | Boston, United States | Artificial intelligence, Cybersecurity | Enlaye, Lambent, Allure Security Technology | 3 | 85 | 41 | 12 | •••@glasswing.vc | (617) ••• | In the CSV |
| 27 | J2 Ventures | Venture capital firm | Boston, United States | Artificial intelligence, Cybersecurity | Cinder Technologies, Code Metal | 2 | 49 | 20 | 0 | In the CSV | ||
| 28 | Material Impact | Venture capital firm | Boston, United States | Biotech, Hardware | Actnano, Tierra Biosciences, Talus Renewables | 45 | 22 | 3 | In the CSV | |||
| 29 | Argon Ventures | Venture capital firm | Boston, United States | Artificial intelligence, Biotech | EnFi | 1 | 42 | 9 | 4 | In the CSV | ||
| 30 | Newpath Management | Private equity firm, Venture capital firm | Boston, United States | Biotech, Health care | Nvelop Therapeutics, Magnet Biomedicine | 23 | 10 | 7 | •••@newpath.partners | In the CSV |
Table 2. Biotech investors in Boston, Massachusetts: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 33.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | MassChallenge | Boston, United States | 26 | 325 | HELIOS, DrizzleX, ScribeUp |
| 2 | RA Capital Management | Boston, United States | 9 | 47 | Delix Therapeutics, Superluminal Medicines, Claris Biotherapeutics |
| 3 | Fidelity | Boston, United States | 7 | 40 | Zipline International, Tenstorrent, SiMa.ai |
| 4 | MassVentures | Boston, United States | 6 | 35 | Emvolon, ZwitterCo, Kytopen |
| 5 | Half Court Ventures | Boston, United States | 4 | 32 | Light Frame, Flow Labs, Beacon Biosignals |
| 6 | Wellington Management | Boston, United States | 4 | 39 | Tabby, Current, Element Biosciences |
| 7 | Cormorant Asset Management | Boston, United States | 4 | 13 | Triveni Bio, Third Arc Bio, BlossomHill Therapeutics |
| 8 | Polaris Partners | Boston, United States | 3 | 73 | Faro AI, Triveni Bio, Whisker Labs |
| 9 | Glasswing Ventures | Boston, United States | 3 | 24 | Enlaye, Lambent, Allure Security Technology |
| 10 | PharmStars | Boston, United States | 2 | 12 | Triomics, Medra AI |
| 11 | J2 Ventures | Boston, United States | 2 | 10 | Cinder Technologies, Code Metal |
| 12 | NYBC Ventures | Boston, United States | 2 | 3 | Vitestro, STRM.BIO |
| 13 | Pillar VC | Boston, United States | 2 | 24 | Addis Energy, OpenHands |
| 14 | Castor Ventures | Boston, United States | 2 | 15 | Pie Systems, Sorcero |
| 15 | Longwood Fund | Boston, United States | 1 | 4 | Channel Medsystems |
Table 3. Biotech investors in Boston, Massachusetts: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Light Frame | Light Frame builds core banking and portfolio management technology for wealth managers. | Fintech | Providence, United States | Seed | $5.1M | 2026-11-10 | $6.8M | Half Court Ventures | 1 to 10 | 2024 |
| Delix Therapeutics | Delix Therapeutics develops psychoplastogen therapies that promote neuroplasticity. | Biotech | Boston, United States | Series C | $100.0M | 2026-11-09 | $244.1M | RA Capital Management | 11 to 50 | 2019 |
| Zipline International Unicorn | Zipline designs, manufactures, and operates drones that deliver medical products. | Hardware | South San Francisco, United States | Series I | $1.5B | 2026-11-05 | $3.6B | Fidelity | 1,001 to 5,000 | 2011 |
| HELIOS | HELIOS provides an AI-powered hockey platform that uses wearable sensors and video to measure player development. | Artificial intelligence | Portsmouth, United States | Seed | $1.1M | 2026-11-03 | $3.9M | MassChallenge | 11 to 50 | 2018 |
| Emvolon | Emvolon converts wasted resources into low-cost green fuels. | Energy | Woburn, United States | Series A | $22.0M | 2026-10-27 | $24.5M | MassVentures | 11 to 50 | 2021 |
| DrizzleX | DrizzleX addresses water waste in apartment buildings. | Software | Santa Fe Springs, United States | Series A | $6.8M | 2026-10-20 | $12.3M | MassChallenge | 11 to 50 | 2019 |
| Tenstorrent Unicorn | Tenstorrent develops AI processors and software for machine learning and data-intensive workloads. | Artificial intelligence | Santa Clara, United States | Series E | $1.5B | 2026-10-19 | $2.5B | Fidelity | 501 to 1,000 | 2016 |
| ScribeUp | ScribeUp embeds subscription management into banking products for fintechs, banks, and credit unions. | Commerce | Los Angeles, United States | Series A | $10.0M | 2026-10-19 | $16.0M | MassChallenge | 11 to 50 | 2021 |
| MuukTest | MuukTest provides an AI-powered software testing platform that helps developers test their software faster. | Artificial intelligence | Raleigh, United States | Seed | $499K | 2026-10-14 | $7.0M | MassChallenge | 11 to 50 | 2019 |
| SiMa.ai | SiMa.ai develops hardware and software for deploying physical AI applications at the edge. | Artificial intelligence | San Jose, United States | Series C | $150.0M | 2026-09-28 | $505.0M | Fidelity | 101 to 250 | 2018 |
Table 4. Biotech investors in Boston, Massachusetts: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 523 | 67% |
| Health care | 275 | 35% |
| Artificial intelligence | 214 | 27% |
| Biotech | 183 | 23% |
| Hardware | 127 | 16% |
| Fintech | 90 | 11% |
| Commerce | 68 | 9% |
| Education | 35 | 4% |
| Cybersecurity | 34 | 4% |
| Energy | 24 | 3% |
Table 5. Biotech investors in Boston, Massachusetts: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Early stage investors | 31 | 94% |
| Seed investors | 26 | 79% |
| Late stage investors | 20 | 61% |
| Venture investors | 17 | 52% |
| Private equity investors | 15 | 45% |
| Post IPO investors | 9 | 27% |
| Debt investors | 5 | 15% |
| Convertible note investors | 2 | 6% |
Table 6. Biotech investors in Boston, Massachusetts by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 6 | 18% |
| 2010s | 13 | 39% |
| 2000s | 6 | 18% |
| 1990s | 4 | 12% |
| 1980s | 1 | 3% |
| 1970s | 1 | 3% |
Table 7. Biotech investors in Boston, Massachusetts by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when it is recorded as an investor in 2 or more funded biotech companies and its headquarters is in Boston, Massachusetts. On 16 November 2026 that is 33 investors.
- 22 rows carry an email address and 17 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 33 rows: 0 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech investors in Boston, Massachusetts are on the list?
- 33, in the file dated 16 November 2026. 24 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 22 of the 33 carry an email address in the download and 17 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 33 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 33 rows, 22 firm email addresses and 17 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 12 of the 22 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.